dabigatran has been researched along with Rheumatoid Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Reheim, MA; Ahmed Gaafar, AG; Atwa, GMK; Cavalu, S; El-Daly, M; Morsy, MA; Saber, S; Yahya, G; Youssef, ME | 1 |
| Brés, V; Clarivet, B; Faillie, JL; Ferreira, R; Hillaire-Buys, D; Jorgensen, C; Lebrun, J; Pers, YM; Robin, P | 1 |
2 other study(ies) available for dabigatran and Rheumatoid Arthritis
| Article | Year |
|---|---|
Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis, Experimental; Arthritis, Rheumatoid; Dabigatran; Fibrinolytic Agents; Freund's Adjuvant; Kallikrein-Kinin System; RANK Ligand; Rats; Thrombin; Toll-Like Receptor 4 | 2022 |
Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Atrial Fibrillation; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Female; Humans; Mesenteric Ischemia; Middle Aged; Receptors, Interleukin-6 | 2016 |